← Evidence map

TrialCancer immunology, immunotherapy : CII2015

Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.

Kathleen M Wesa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25351719